Treatment response of CNS high‐grade neuroepithelial tumors with MN1 alteration
- 22 September 2020
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 67 (12) , e28627
Abstract
Central nervous system high‐grade neuroepithelial tumor with MN1 alteration (CNS HGNET‐MN1) is a rare recently described entity. Fourteen CNS HGNET‐MN1 patients were identified using genome‐wide methylation arrays/RT‐PCR across seven institutions. All patients had surgery (gross total resection: 10; subtotal resection: four) as initial management followed by observation alone in three patients, followed by radiotherapy in eight patients (focal: five; craniospinal: two; CyberKnife: one) and systemic chemotherapy in three patients. Seven patients relapsed; five local and two metastatic, despite adjuvant radiotherapy, of which three died. Treatment of CNS HGNET‐MN1 remains a major treatment challenge despite aggressive surgical resections and upfront radiotherapy, warranting new approaches to this rare malignancy.Keywords
All Related Versions
This publication has 11 references indexed in Scilit:
- Spinal cord astroblastoma with an EWSR1‐BEND2 fusion classified as a high‐grade neuroepithelial tumour with MN1 alterationNeuropathology and Applied Neurobiology, 2019
- Pediatric methylation class HGNET-MN1: unresolved issues with terminology and gradingActa Neuropathologica Communications, 2019
- MN1 rearrangement in astroblastoma: study of eight cases and review of literatureBrain Tumor Pathology, 2019
- Role of DNA Methylation Profile in Diagnosing Astroblastoma: A Case Report and Literature ReviewFrontiers in Genetics, 2019
- Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosisActa Neuropathologica Communications, 2019
- Advances in the classification of pediatric brain tumors through DNA methylation profiling: From research tool to frontline diagnosticCancer, 2018
- Brainstem astroblastoma with MN1 translocationNeuropathology, 2018
- The ten-year evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusionScientific Reports, 2018
- Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entitiesBrain Pathology, 2017
- New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETsCell, 2016